{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:01:46Z","timestamp":1789675306334,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To identify the most reproducible visual scoring approach on radiological criteria of the 2022 progressive pulmonary fibrosis (PPF) guideline and compare its association with pulmonary function test (PFT) decline against quantitative 3D-CT volume-histogram analysis (VHA) metrics in fibrosing interstitial lung disease (ILD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In this single-center retrospective study, 92 patients with fibrosing ILD underwent paired thin-section CT and PFTs at a median 44.5-month interval. Five guideline-defined CT features were visually scored as a percentage of lung involvement on five axial sections at baseline and follow-up; the sum of changes in each feature constituted the total visual score change (\u0394CT-score). Interobserver reliability was assessed using intraclass correlation coefficients (ICC). Quantitative metrics included changes in skewness, kurtosis, and entropy derived from VHA, and total-lung volume change (\u0394V-LUNG) through volumetric analysis. Associations with changes in percent-predicted forced vital capacity (%FVC) and diffusing capacity for carbon monoxide (%DLCO) were evaluated using Spearman correlation coefficients. Discriminatory performance for disease progression was assessed using receiver operating characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      \u0394CT-score demonstrated excellent interobserver reliability (ICC, 0.94\u20130.96) and strong correlations with VHA metrics (Spearman r: \u0394skewness, \u2212\u20090.78; \u0394kurtosis, \u2212\u20090.74; \u0394entropy, 0.73). VHA metrics correlated substantially with \u0394%FVC (r: \u0394skewness, 0.64; \u0394kurtosis, 0.61; \u0394entropy, \u2212\u20090.61), comparable to \u0394CT-score (r, \u2212\u20090.60), whereas correlations with \u0394%DLCO were moderate (r: \u0394skewness, 0.58; \u0394kurtosis, 0.55; \u0394entropy, \u2212\u20090.58; \u0394CT-score, \u2212\u20090.48). \u0394V-LUNG correlated with \u0394%FVC (r, 0.61) and \u0394%DLCO (r, 0.51). All correlations were statistically significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). All metrics showed good discriminatory performance for radiological and\/or physiological evidence of disease progression by PPF guideline definition, with area-under-the-curve values of 0.76\u20130.89.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>VHA metrics demonstrated utility comparable to reproducible visual scoring for identifying radiological progression and physiological decline in fibrosing ILD. Automated VHA can offer an objective, reproducible alternative to laborious visual assessment for disease progression in fibrosing ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11604-026-02070-x","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:56:23Z","timestamp":1789628183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of fibrosing interstitial lung disease progression: CT visual score on radiological progressive pulmonary fibrosis criteria versus 3D-CT volume-histogram analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-3446","authenticated-orcid":false,"given":"Tomonori","family":"Chikasue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4830-4033","authenticated-orcid":false,"given":"Akiko","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1237-2349","authenticated-orcid":false,"given":"Takeshi","family":"Johkoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0769-7763","authenticated-orcid":false,"given":"Kotaro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2724-8014","authenticated-orcid":false,"given":"Akiko","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-3729","authenticated-orcid":false,"given":"Shuji","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8813-8108","authenticated-orcid":false,"given":"Shuichi","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-4599","authenticated-orcid":false,"given":"Yoshiaki","family":"Zaizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-3504","authenticated-orcid":false,"given":"Masaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6972-1338","authenticated-orcid":false,"given":"Masaki","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8681-7588","authenticated-orcid":false,"given":"Kiminori","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2070_CR1","doi-asserted-by":"publisher","first-page":"180100","DOI":"10.1183\/16000617.0100-2018","volume":"28","author":"V Cottin","year":"2019","unstructured":"Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S. Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019;28:180100.","journal-title":"Eur Respir Rev"},{"key":"2070_CR2","doi-asserted-by":"publisher","first-page":"170053","DOI":"10.1183\/16000617.0053-2017","volume":"26","author":"SE Torrisi","year":"2017","unstructured":"Torrisi SE, Pavone M, Vancheri A, Vancheri C. When to start and when to stop antifibrotic therapies. Eur Respir Rev. 2017;26:170053.","journal-title":"Eur Respir Rev"},{"key":"2070_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/14397595.2020.1826665","volume":"31","author":"S Makino","year":"2021","unstructured":"Makino S. Progressive fibrosing interstitial lung diseases: a new concept and indication of nintedanib. Mod Rheumatol. 2021;31:13\u20139.","journal-title":"Mod Rheumatol"},{"key":"2070_CR4","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381:1718\u201327.","journal-title":"N Engl J Med"},{"key":"2070_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"2070_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/thoraxjnl-2013-203843","volume":"69","author":"SL Walsh","year":"2014","unstructured":"Walsh SL, Sverzellati N, Devaraj A, Keir GJ, Wells AU, Hansell DM. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax. 2014;69:216\u201322.","journal-title":"Thorax"},{"key":"2070_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s11604-019-00864-w","volume":"37","author":"J Tominaga","year":"2019","unstructured":"Tominaga J, Bankier AA, Lee KS, Leung AN, Remy-Jardin M, Akira M, et al. Inter-observer agreement in identifying traction bronchiectasis on computed tomography: its improvement with the use of the additional criteria for chronic fibrosing interstitial pneumonia. Jpn J Radiol. 2019;37:773\u201380.","journal-title":"Jpn J Radiol"},{"key":"2070_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1148\/radiol.12112516","volume":"266","author":"T Watadani","year":"2013","unstructured":"Watadani T, Sakai F, Johkoh T, Noma S, Akira M, Fujimoto K, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology. 2013;266:936\u201344.","journal-title":"Radiology"},{"key":"2070_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1164\/rccm.201711-2174OC","volume":"198","author":"J Jacob","year":"2018","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, van Moorsel CHM, van Es HW, van Beek FT, et al. Predicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis. Am J Respir Crit Care Med. 2018;198:767\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"2070_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S2213-2600(18)30286-8","volume":"6","author":"SLF Walsh","year":"2018","unstructured":"Walsh SLF, Calandriello L, Silva M, Sverzellati N. Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study. Lancet Respir Med. 2018;6:837\u201345.","journal-title":"Lancet Respir Med"},{"key":"2070_CR11","doi-asserted-by":"publisher","first-page":"e222828","DOI":"10.1148\/radiol.222828","volume":"307","author":"KJ Chae","year":"2023","unstructured":"Chae KJ, Lim S, Seo JB, Hwang HJ, Choi H, Lynch D, et al. Interstitial lung abnormalities at CT in the Korean national lung cancer screening program: prevalence and deep learning-based texture analysis. Radiology. 2023;307:e222828.","journal-title":"Radiology"},{"key":"2070_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12931-017-0527-8","volume":"18","author":"SY Ash","year":"2017","unstructured":"Ash SY, Harmouche R, Vallejo DL, Villalba JA, Ostridge K, Gunville R, et al. Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis. Respir Res. 2017;18:45.","journal-title":"Respir Res"},{"key":"2070_CR13","doi-asserted-by":"publisher","first-page":"20210957","DOI":"10.1259\/bjr.20210957","volume":"95","author":"Y AlDalilah","year":"2022","unstructured":"AlDalilah Y, Ganeshan B, Endozo R, Bomanji J, Porter JC, Machado M, et al. Filtration-histogram based texture analysis and CALIPER based pattern analysis as quantitative CT techniques in idiopathic pulmonary fibrosis: head-to-head comparison. Br J Radiol. 2022;95:20210957.","journal-title":"Br J Radiol"},{"key":"2070_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40248-018-0155-2","volume":"13","author":"SE Torrisi","year":"2018","unstructured":"Torrisi SE, Palmucci S, Stefano A, Russo G, Torcitto AG, Falsaperla D, et al. Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes. Multidiscip Respir Med. 2018;13:43.","journal-title":"Multidiscip Respir Med"},{"key":"2070_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11604-025-01880-9","volume":"44","author":"T Chikasue","year":"2026","unstructured":"Chikasue T, Sumikawa H, Sumi A, Matsumoto K, Murotani K, Tanoue S, et al. Volume histogram analysis of whole-lung CT: differentiating usual from nonspecific interstitial pneumonias and predicting prognosis. Jpn J Radiol. 2026;44:291\u2013302.","journal-title":"Jpn J Radiol"},{"key":"2070_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2214\/ajr.161.6.8249719","volume":"161","author":"AU Wells","year":"1993","unstructured":"Wells AU, Rubens MB, du Bois RM, Hansell DM. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol. 1993;161:1159\u201365.","journal-title":"AJR Am J Roentgenol"},{"key":"2070_CR17","doi-asserted-by":"publisher","first-page":"e232558","DOI":"10.1148\/radiol.232558","volume":"310","author":"AA Bankier","year":"2024","unstructured":"Bankier AA, MacMahon H, Colby T, Gevenois PA, Goo JM, Leung ANC, et al. Fleischner society: glossary of terms for thoracic imaging. Radiology. 2024;310:e232558.","journal-title":"Radiology"},{"key":"2070_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008;177:1248\u201354.","journal-title":"Am J Respir Crit Care Med"},{"key":"2070_CR19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11547-025-01985-1","volume":"130","author":"E Baratella","year":"2025","unstructured":"Baratella E, Borghesi A, Calandriello L, Cortese G, Della Casa G, Giraudo C, et al. Quantification of progressive pulmonary fibrosis by visual scoring of HRCT images: recommendations from Italian chest radiology experts. Radiol Med. 2025;130:965\u201377.","journal-title":"Radiol Med"},{"key":"2070_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/thx.2010.137190","volume":"66","author":"C Tcherakian","year":"2011","unstructured":"Tcherakian C, Cottin V, Brillet PY, Freynet O, Naggara N, Carton Z, et al. Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease. Thorax. 2011;66:226\u201331.","journal-title":"Thorax"},{"key":"2070_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.semtcvs.2019.01.004","volume":"31","author":"Y Sekine","year":"2019","unstructured":"Sekine Y, Itoh T, Toyoda T, Kaiho T, Koh E, Kamata T, et al. Precise anatomical sublobar resection using a 3D medical image analyzer and fluorescence-guided surgery with transbronchial instillation of indocyanine green. Semin Thorac Cardiovasc Surg. 2019;31:595\u2013602.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2070_CR22","doi-asserted-by":"publisher","first-page":"ezac537","DOI":"10.1093\/ejcts\/ezac537","volume":"62","author":"M Kitazume","year":"2022","unstructured":"Kitazume M, Tane S, Shimizu N, Kitamura Y, Maniwa Y, Nishio W. Segmental volumetric analysis with a ventilated or perfused area: identifying the intersegmental plane. Eur J Cardiothorac Surg. 2022;62:ezac537.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2070_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.13-1474","volume":"145","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145:723\u20138.","journal-title":"Chest"},{"key":"2070_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12931-020-01371-7","volume":"21","author":"N Taha","year":"2020","unstructured":"Taha N, D\u2019Amato D, Hosein K, Ranalli T, Sergiacomi G, Zompatori M, et al. Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters? Respir Res. 2020;21:119.","journal-title":"Respir Res"},{"key":"2070_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12890-022-02105-9","volume":"22","author":"M Mononen","year":"2022","unstructured":"Mononen M, Saari E, Hasala H, Kettunen HP, Suoranta S, Nurmi H, et al. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases. BMC Pulm Med. 2022;22:313.","journal-title":"BMC Pulm Med"},{"key":"2070_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1183\/09031936.00201809","volume":"38","author":"N Sverzellati","year":"2011","unstructured":"Sverzellati N, Guerci L, Randi G, Calabr\u00f2 E, La Vecchia C, Marchian\u00f2 A, et al. Interstitial lung diseases in a lung cancer screening trial. Eur Respir J. 2011;38:392\u2013400.","journal-title":"Eur Respir J"},{"key":"2070_CR27","doi-asserted-by":"publisher","first-page":"e0149240","DOI":"10.1371\/journal.pone.0149240","volume":"11","author":"F Salaffi","year":"2016","unstructured":"Salaffi F, Carotti M, Di Donato E, Di Carlo M, Ceccarelli L, Giuseppetti G. Computer-aided tomographic analysis of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). Correlation with pulmonary physiologic tests and patient-centred measures of perceived dyspnea and functional disability. PLoS ONE. 2016;11:e0149240.","journal-title":"PLoS ONE"},{"key":"2070_CR28","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1007\/s00330-020-07594-y","volume":"31","author":"J Park","year":"2021","unstructured":"Park J, Jung J, Yoon SH, Hong H, Kim H, Kim H, et al. CT quantification of the heterogeneity of fibrosis boundaries in idiopathic pulmonary fibrosis. Eur Radiol. 2021;31:5148\u201359.","journal-title":"Eur Radiol"},{"key":"2070_CR29","doi-asserted-by":"publisher","first-page":"20221160","DOI":"10.1259\/bjr.20221160","volume":"96","author":"S Palmucci","year":"2023","unstructured":"Palmucci S, Tiralongo F, Galioto F, Toscano S, Reali L, Scavone C, et al. Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes. Br J Radiol. 2023;96:20221160.","journal-title":"Br J Radiol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02070-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:02:05Z","timestamp":1789671725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-026-02070-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":29,"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02070-x","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KF received lecture fees from Boehringer Ingelheim, AstraZeneca, Kyorin Inc, and Bayer Pharma Japan; TJ received lecture fees from Boehringer Ingelheim, AstraZeneca, and Kyorin Inc. The other authors have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective single-center study was approved by the Ethical Committee of Kurume University (approval number: 22218). This study was conducted in accordance with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study, the requirement for written informed consent was waived by the institutional review board. Instead, an opt-out method was used to provide patients with the opportunity to refuse participation.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}